Proto-oncogenes in Thyroid Carcinomas
Author Information
Author(s): P. Terrier, Z.-M. Sheng, M. Schlumberger, M. Tubiana, B. Caillou, J.-P. Travagli, P. Fragu, C. Parmentier, G. Rioul
Primary Institution: Institut Gustave Roussy
Hypothesis
The study aims to characterize the expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas and analyze their relationship with prognosis and differentiation.
Conclusion
The overexpression of c-myc and c-fos genes in thyroid carcinomas is independent of alterations in their loci and is associated with prognosis.
Supporting Evidence
- High levels of c-myc RNA were found in 57% of cancer patients.
- High levels of c-fos RNA were found in 61% of cancer patients.
- Elevated c-myc RNA levels were more frequent in thyroid carcinomas with unfavorable prognosis.
Takeaway
This study looked at thyroid cancer samples and found that certain genes were more active in cancer cells, which might help doctors understand how serious the cancer is.
Methodology
Tissue specimens were analyzed using Southern blot hybridization for c-myc and c-fos proto-oncogenes, and RNA levels were measured by Northern blot.
Limitations
The study may not account for all variables affecting gene expression and prognosis.
Participant Demographics
The study included 23 patients with thyroid carcinoma, 22 with thyroid adenoma, 3 with Graves' disease, and 8 normal thyroid glands.
Statistical Information
P-Value
<0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website